当前位置: X-MOL 学术EMBO Mol. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitis
EMBO Molecular Medicine ( IF 9.0 ) Pub Date : 2022-07-04 , DOI: 10.15252/emmm.202115653
Mor Paldor 1 , Orr Levkovitch-Siany 1 , Dana Eidelshtein 1 , Revital Adar 1 , Claes D Enk 2 , Yitzhak Marmary 1 , Sharona Elgavish 3 , Yuval Nevo 3 , Hadar Benyamini 3 , Inbar Plaschkes 3 , Shiri Klein 1 , Alex Mali 4 , Stefan Rose-John 5 , Amnon Peled 1 , Eithan Galun 1 , Jonathan H Axelrod 1
Affiliation  

Irradiation-induced alopecia and dermatitis (IRIAD) are two of the most visually recognized complications of radiotherapy, of which the molecular and cellular basis remains largely unclear. By combining scRNA-seq analysis of whole skin-derived irradiated cells with genetic ablation and molecular inhibition studies, we show that senescence-associated IL-6 and IL-1 signaling, together with IL-17 upregulation and CCR6+-mediated immune cell migration, are crucial drivers of IRIAD. Bioinformatics analysis colocalized irradiation-induced IL-6 signaling with senescence pathway upregulation largely within epidermal hair follicles, basal keratinocytes, and dermal fibroblasts. Loss of cytokine signaling by genetic ablation in IL-6−/− or IL-1R−/− mice, or by molecular blockade, strongly ameliorated IRIAD, as did deficiency of CCL20/CCR6-mediated immune cell migration in CCR6−/− mice. Moreover, IL-6 deficiency strongly reduced IL-17, IL-22, CCL20, and CCR6 upregulation, whereas CCR6 deficiency reciprocally diminished IL-6, IL-17, CCL3, and MHC upregulation, suggesting that proximity-dependent cellular cross talk promotes IRIAD. Therapeutically, topical application of Janus kinase blockers or inhibition of T-cell activation by cyclosporine effectively reduced IRIAD, suggesting the potential of targeted approaches for the treatment of dermal side effects in radiotherapy patients.

中文翻译:

单细胞转录组学揭示了与衰老相关的 IL-6/CCR6 轴驱动放射性皮炎

辐照性脱发和皮炎 (IRIAD) 是两种最直观的放射治疗并发症,其分子和细胞基础仍不清楚。通过将整个皮肤衍生的辐照细胞的 scRNA-seq 分析与基因消融和分子抑制研究相结合,我们发现衰老相关的 IL-6 和 IL-1 信号传导,以及 IL-17 上调和 CCR6 +介导的免疫细胞迁移,是 IRIAD 的关键驱动因素。生物信息学分析主要在表皮毛囊、基底角质形成细胞和真皮成纤维细胞内共定位辐射诱导的 IL-6 信号与衰老通路上调。IL-6 -/-或 IL-1R -/-基因消融导致细胞因子信号丢失小鼠或通过分子阻断显着改善了 IRIAD,正如 CCR6 -/-小鼠中 CCL20/CCR6 介导的免疫细胞迁移缺陷一样。此外,IL-6 缺乏会强烈降低 IL-17、IL-22、CCL20 和 CCR6 的上调,而 CCR6 缺乏会相互降低 IL-6、IL-17、CCL3 和 MHC 的上调,这表明邻近依赖性细胞串扰促进艾瑞德。在治疗上,Janus 激酶阻滞剂的局部应用或环孢菌素抑制 T 细胞活化可有效降低 IRIAD,这表明靶向方法治疗放射治疗患者皮肤副作用的潜力。
更新日期:2022-07-04
down
wechat
bug